SAO:RADL3
Raia Drogasil S.A. · SAO · Healthcare · BRL · FY for 2025
Figures on this page computed 2026-11-07 18:41 UTC
Last close
n/aBRL
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
18.8xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
- Computed from the filing for 2025
15.1%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
2.9%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
2.3%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
1.21Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
2.6%Dividend yield
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
Safety is the furthest below its sector's middle: 0.40 against 0.57 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales1.79x
Its own average over 10 years, 24.72B.
- Profit1.62x
Its own average over 10 years, 801.6M.
- Free cash flow2.22x
Its own average over 10 years, 462.3M.
- Debt1.92x
Its own average over 10 years, 4.61B.
- Pricen/a
Its own average over 0 years. Market data
Free cash flow is furthest from its own average, at 2.22 times.
The filed years, as a table
10Each line is 100 at 2016-12-31, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2016-12-31 | 100.0 | 100.0 | 100.0 |
| 2017-12-31 | 117.4 | 114.2 | 100.1 |
| 2018-12-31 | 131.5 | 112.2 | 99.9 |
| 2019-12-31 | 156.0 | 172.5 | 100.2 |
| 2020-12-31 | 178.3 | 108.2 | 100.3 |
| 2021-12-31 | 214.3 | 168.0 | 100.3 |
| 2022-12-31 | 258.2 | 222.5 | 96.4 |
| 2023-12-31 | 301.8 | 235.7 | 98.9 |
| 2024-12-31 | 345.3 | 267.5 | 96.5 |
| 2025-12-31 | 393.1 | 289.7 | 96.7 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- BRL
How profit was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- BRL
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- BRL
Figures behind the shape
Growth
17.1%faster is higher, placed against 4,950 companies as of 2026-11-06
Five-year revenue growth rate17.1%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
Five-year EPS growth rate23.1%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
One-year change in net income8.3%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
Returns on capital
15.1%higher is higher, placed against 5,089 companies as of 2026-11-06
Return on invested capital15.1%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity17.7%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets5.1%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
Margins
24.8%wider is higher, placed against 3,412 companies as of 2026-11-06
Gross margin24.8%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin6.0%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin2.9%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin2.3%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
Price
18.8xcheaper is higher, placed against 4,362 companies as of 2026-11-06
Price to earnings18.8x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
- Computed from the filing for 2025
Price to book3.4x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDA7.1x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio0.6x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
Safety
1.21safer is higher, placed against 3,227 companies as of 2026-11-06
Debt to equity1.21
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio1.46
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coverage2.5x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Score3.24
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
What it pays out
2.6%more, and better covered, is higher, placed against 1,091 companies as of 2026-11-06
Dividend yield2.6%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
Payout ratio50.3%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ratio1.6x
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- BRL
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.